Category: Blood Test
The CA-125 Tumor Marker Test is a blood test used to measure the level of Cancer Antigen 125 (CA-125) in the bloodstream. CA-125 is a protein that can be found at higher levels in some people with certain cancers, particularly epithelial ovarian cancer. It may also be elevated in cancers involving the fallopian tubes, peritoneum, and, in some cases, the endometrium.
CA-125 is known as a tumor marker, but it is important to understand that an elevated CA-125 level does not automatically mean that a person has cancer. Many non-cancerous conditions can also increase CA-125 levels.
For this reason, the CA-125 test is generally not recommended as a standalone screening test for ovarian cancer in women who have no symptoms and are not considered high risk.
CA-125 can increase due to conditions such as endometriosis, menstruation, pregnancy, pelvic inflammatory disease, uterine fibroids, liver disease, and other inflammatory conditions.
The test is usually performed by collecting a blood sample from a vein in the arm. The laboratory measures CA-125 and generally reports the result in U/mL (units per milliliter).
A commonly used reference value is less than 35 U/mL, although the exact reference range can vary between laboratories.
The CA-125 test is particularly useful for people who have already been diagnosed with ovarian cancer or another CA-125-producing cancer. In these situations, doctors may measure CA-125 before treatment and then repeat it at intervals to monitor changes.
A decreasing CA-125 level during treatment may indicate that the cancer is responding, while a rising level may indicate persistent disease or recurrence. However, CA-125 results must always be interpreted together with imaging and other clinical information.
The test may also be used when a doctor is investigating an ovarian or pelvic mass. In this situation, CA-125 is only one part of the evaluation and may be combined with ultrasound or other imaging.
CA-125 levels can naturally change during the menstrual cycle, particularly around menstruation. Therefore, the timing of the test may be considered when interpreting the result.
The main purpose of the CA-125 Tumor Marker Test is to help evaluate and monitor certain cancers, particularly ovarian cancer.
One of the most important uses is monitoring patients who have already been diagnosed with ovarian cancer. If CA-125 was elevated before treatment, repeated measurements can help doctors observe how the marker changes during treatment.
For example, after surgery or chemotherapy, a significant decrease in CA-125 may be consistent with a reduction in cancer activity. If the level remains elevated or begins increasing again, the healthcare team may investigate further.
CA-125 can also be used as part of follow-up after treatment. A rising level may raise concern about recurrence, although it does not prove that cancer has returned.
Doctors may also order CA-125 when an imaging test identifies an ovarian or pelvic mass. The result can provide additional information when combined with ultrasound, CT, MRI, physical examination, and medical history.
However, an elevated CA-125 does not distinguish cancer from benign conditions by itself.
Possible non-cancerous causes of an elevated CA-125 include:
Menstruation
Endometriosis
Pregnancy
Pelvic inflammatory disease
Uterine fibroids
Liver disease
Certain abdominal or pelvic inflammatory conditions
CA-125 may also increase in other cancers, including some cancers affecting the fallopian tubes, peritoneum, endometrium, pancreas, breast, colon, or other organs.
Another purpose of the test may be evaluating a patient who has symptoms that require further investigation, such as persistent abdominal or pelvic discomfort, abdominal swelling, unexplained bloating, feeling full quickly, or unexplained changes in urinary or bowel habits.
However, these symptoms are common and can be caused by many conditions other than ovarian cancer.
CA-125 is generally not suitable as a general screening test for ovarian cancer in average-risk women without symptoms. Using it alone can lead to false-positive results and unnecessary additional investigations.
For women with certain inherited genetic risks, such as those carrying specific cancer-predisposition gene variants, doctors may recommend individualized surveillance or risk-reduction strategies. CA-125 may sometimes be used in selected high-risk situations, but the appropriate approach should be determined by a specialist.
Overall, the purpose of the CA-125 test is to support the evaluation of suspected ovarian or related cancers, monitor treatment response, follow known disease, and help assess possible recurrence when interpreted with other clinical findings.
Preparation for the CA-125 Test is generally simple. Fasting is usually not required when CA-125 is being tested alone.
If CA-125 is ordered along with other blood tests that require fasting, the healthcare provider may provide separate fasting instructions.
Patients should follow the laboratory's specific instructions.
The test requires a small blood sample, usually collected from a vein in the arm.
Patients should tell the healthcare professional about all medications, vitamins, supplements, and medical conditions.
It is also useful to mention whether the patient is currently menstruating, pregnant, or has recently experienced a pelvic infection or inflammatory condition. These factors can influence CA-125 levels.
Patients should not stop prescribed medicines before testing unless specifically instructed by their healthcare provider.
For patients using CA-125 to monitor ovarian cancer, the doctor may recommend testing at specific intervals. Repeated testing can be more informative when results are compared over time.
If possible, follow-up tests may be performed using the same laboratory and testing method because different laboratories can use different analytical systems.
The blood collection usually takes only a few minutes.
A healthcare professional cleans the skin, inserts a small needle into a vein, and collects the blood sample.
Some people may experience mild pain, bruising, or tenderness at the collection site.
No special recovery period is normally required after the test.
If the test is being performed to investigate an ovarian or pelvic mass, the healthcare provider may order additional tests at the same time or afterward. These may include pelvic ultrasound, transvaginal ultrasound, CT scan, MRI, CBC, liver function tests, or other tumor markers.
Patients should provide accurate information about previous ovarian or gynecological conditions because this can help with interpretation.
The commonly used reference range for the CA-125 Tumor Marker Test is:
CA-125: Less than 35 U/mL
However, reference ranges may vary between laboratories. The normal range printed on the laboratory report should always be followed.
A simplified interpretation is:
CA-125 below 35 U/mL: Generally considered within the commonly used reference range.
CA-125 above 35 U/mL: Considered elevated and may require further evaluation depending on the patient's symptoms and medical history.
An elevated CA-125 level does not automatically mean ovarian cancer.
CA-125 can increase during menstruation and pregnancy and may also rise because of endometriosis, pelvic inflammatory disease, uterine fibroids, liver disease, and other benign conditions.
The amount of elevation also cannot be used by itself to determine whether cancer is present or how advanced it may be.
A very high CA-125 level can occur in ovarian cancer, but substantial elevations can also occur in some non-cancerous conditions.
Similarly, a normal CA-125 level does not completely rule out ovarian cancer. Some ovarian cancers do not produce significant amounts of CA-125, particularly certain non-epithelial ovarian cancers.
For this reason, doctors usually consider CA-125 alongside pelvic imaging, physical examination, symptoms, age, medical history, and other laboratory results.
For patients with confirmed ovarian cancer, the trend over time can be more useful than one isolated value.
If CA-125 was elevated before treatment and decreases after surgery or chemotherapy, this may suggest that treatment is having an effect.
If the level later rises significantly, doctors may investigate for possible recurrence or progression. However, temporary increases can occur for reasons unrelated to cancer.
A rising CA-125 result should therefore not be interpreted as proof of recurrence without additional clinical assessment.
If CA-125 is elevated in a patient who has an ovarian or pelvic mass, the healthcare provider may recommend further imaging or specialist evaluation.
Possible additional investigations include:
Pelvic or transvaginal ultrasound
CT scan
MRI
Other blood tests
Additional tumor markers
Gynecological examination
Tissue sampling or biopsy when clinically indicated
It is also important to distinguish CA-125 from other tumor markers. Tests such as CA 19-9, AFP, and CEA are associated with different cancers and clinical situations. The appropriate marker depends on the suspected disease.
CA-125 should not be used as a substitute for medical evaluation when symptoms are present.
Persistent symptoms such as abdominal or pelvic pain, ongoing bloating, increasing abdominal size, unexplained weight loss, abnormal vaginal bleeding, or feeling full quickly should be discussed with a healthcare professional, especially if they are new or persistent.
Overall, the CA-125 Tumor Marker Test is a useful blood test primarily associated with the evaluation and monitoring of ovarian and related cancers. A commonly used reference value is less than 35 U/mL, but laboratory ranges can vary. An elevated CA-125 level can occur because of cancer as well as many non-cancerous conditions, including menstruation, endometriosis, pregnancy, pelvic inflammation, and liver disease. A normal result also cannot completely exclude ovarian cancer. Therefore, CA-125 is most useful when interpreted with ultrasound or other imaging, symptoms, medical history, physical examination, and changes in the marker level over time.
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. In an emergency, call emergency services immediately.